TrialThe Lancet. Infectious diseases2018

Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial.

Khalequ Zaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.